Farmacia italiana online: acquisto cialis in Italia e Roma senza ricetta.

Hcl085 565.580

Q J Med 2006; 99:565–579doi:10.1093/qjmed/hcl085 From the 1Department of Internal Medicine C and 2Metabolic Unit, Kaplan Medical Centre,Rehovot, Israel IntroductionThe prevalence of overweight and obesity is Initial data from actuarial studies of more than increasing worldwide.1 A comparison of data from 4 million men and women showed a direct positive 1976–802 with that from 1999–2000 shows that the association between body weight and overall prevalence of overweight (defined as body mass mortality rates.6 Subsequent studies confirmed index, BMI, of 25–29.9 kg/m2) increased from 46% increased mortality risk above a certain threshold, to 64.5%, and the prevalence of obesity (BMI but found a U-shaped association between weight 530 kg/m2) doubled to 30.5%. The epidemic of and mortality.7,8 In the Build study,9 there was obesity is not just isolated to the US, but is a higher mortality in lean subjects, but there worldwide,3,4 including less affluent countries.4 was no adjustment for smoking. The American Cancer Society found a much stronger association including genetic, metabolic, behavioural and between leanness and mortality, specifically cancer environmental. The rapid increase in prevalence mortality, in the group of smokers compared to suggests that behavioural and environmental influ- ences predominate, rather than biological changes.
The Harvard Alumni Study11 was a prospective We summarize data from many studies evaluating cohort study of more than 19 000 middle-aged men.
the impact of obesity on mortality and morbidity, It also noted a U-shaped relation between BMI discuss some controversies and provide practical and mortality after adjustment for age, cigarette guidelines for managing obese patients.
smoking and physical activity. However, afterexcluding those who had ever smoked and thosewho died within the first 5 years of follow-up, there was no evidence for increased mortality in those mortality was noted in those who weighed 20% Direct associations between obesity and several diseases, including diabetes mellitus, hypertension, A direct relationship between BMI and mortality dyslipidaemia and ischaemic heart disease, are well was also described in a cohort of more than 8000 recognized. Despite this, the relationship between Seventh Day Adventists, with the lowest mortality body weight and all-cause mortality is more rate found in men with a BMI <22.3 kg/m2.12 This controversial. A very high degree of obesity group is usually lean by choice, and therefore their (BMI 535 kg/m2) seems to be linked to higher leanness is less likely to be the result of cigarette mortality rates,5 but the relationship between more modest degrees of overweight and mortality is increased risk of mortality in women. There have Address correspondence to Dr S.D.H. Malnick, Department of Internal Medicine C, Kaplan Medical Centre,Rehovot 76100, Israel. email: stevash@trendline.co.il ! The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians.
All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org been some reports that did not find a relationship and for effect modification by age, they found an between BMI and mortality in women,13–15 but increased mortality associated both with being due to the small number of endpoints occurring underweight and with being obese. Notably, the in these cohorts, these studies lacked sufficient increased mortality was found in subjects with a power. Several larger studies showed a significant BMI 535 kg/m2, but there was no increase in association between body weight8–10 or BMI and mortality in the in the less obese groups. In addition, mortality.16 Notably, the Nurses’ Health Study, there was a decline in the relative risk of mortality showed a U-shaped relationship between BMI and according to BMI categories from NHANES I to all-cause mortality.16 Another recent study found a U-shaped association between weight and This finding suggests that the attenuation in the mortality in a large cohort of Chinese men and strength of the association between obesity and mortality is related to the improvement in the There are several explanations for the discrepan- standard medical care that has resulted in reduced cies observed in the above epidemiological studies.
cardiovascular mortality in recent years. Age- There may be an adverse effect of leanness and adjusted death rates from heart disease (per leanness can be a surrogate marker of underlying 100 000 population) declined from 412.1 in 1980 diseases.18 The possibility that there may be some to 240.8 in 2002.26 In addition, there was a beneficial effect of mild degree of excess body decrease in the prevalence of hypercholesterolemia weight on overall survival, also cannot be entirely and smoking, but not of diabetes, between 1960–62 ruled out. For example, in the INTERHEART study, and 1999–2000.27 These changes occurred despite high hip circumference had a negative predictive the marked increase in the prevalence of obesity value for myocardial infarction, while high waist circumference was associated with high rates ofmyocardial infarction, implying that consideringonly the BMI and ignoring fat distribution may bemisleading.19 Weight or BMI may be relatively low in an elderly person with little lean body mass relative to adipose tissue. The correlations between BMI and There is a strong association between obesity and more direct measures of adiposity (e.g. underwater type 2 diabetes mellitus, in both genders and all ethnic groups. Data from the Nurses’ Health Study Furthermore, reported correlations between waist– showed an age-adjusted relative risk of 40 for hip ratios and visceral adipose tissue volume diabetes in women with a BMI 531 kg/m2, com- pared with women with a BMI <22 kg/m2.28 Other limitations of several epidemiological studies are: partial adjustment for confounding A similar risk was shown for men in the Health factors (such as physical fitness, type of diet, family Professionals Follow-up Study: a BMI of 535 kg/m2 history, weight cycling, use of diet drugs, economic was associated with an age-adjusted relative status), inclusion of self-reported data, not taking risk for diabetes of 60.9, compared with a BMI of into account the age of onset of obesity and not <23 kg/m2.29 In addition, weight gain appears to estimating the obesity-attributable mortality. It has precede the development of diabetes. In the Pima been estimated that the excess mortality associated Indians, a group with a high incidence of type 2 with obesity in the Framingham study is due to the diabetes, body weight was shown to increase by effect of weight cycling, and that participants with 30 kg from a mean of 60 kg to a mean of 90 kg in stable body weights were not at increased risk.23 the years prior to the diagnosis of diabetes.30 The A similar finding has been reported in the National importance of obesity as a risk factor for diabetes in the presence of other risk factors is underlined by a recent report from Israel. In a cohort of relatively Flegal et al. recently made an estimation of young men in the Israel Defence Forces who relative risks of mortality associated with different were subjected to regular physical examinations, levels of BMI from the nationally representative the combination of a fasting plasma glucose in NHANES I, II and III, and applied these relative the high-normal range (91–99 mg/dl) and a BMI risks to the distribution of BMI and other covariates of 430 kg/m2 was associated with a hazard ratio from NHANES 1999–2002 data to estimate attrib- of 8.29 for developing diabetes, compared to those utable fractions and number of excess deaths related men with a BMI <25 kg/m2 and a fasting plasma to obesity.25 After adjusting for confounding factors Hypertension is strongly linked to obesity. The In addition to the link between obesity and mortality Swedish Obesity Study showed hypertension to be from cardiovascular disease, obesity is associated present at baseline in 44–51% of obese sub- with increased risks of coronary artery disease, heart jects.32,33 In the Nurses’ Health Study, BMI at age 18 years and in mid-life were both positivelyassociated with the occurrence of hypertension.34,35 Furthermore, weight gain was also associated with An increased risk of coronary artery disease (CAD) an increased risk. The relative risk for developing in the overweight was apparent in both the hypertension in women who gained 5–9.9 kg was Framingham Heart Study and the Nurses Health 1.7, and in those who gained 425 kg, the relative Study.6,34,36,43,44 In the Nurses Health Study, risk was 5.2.34 Similar findings in men were the adjusted relative risk for CAD (taking BMI apparent in the Health Professionals Study.29 It has of 21 kg/m2 as a reference value) increased been estimated from the Framingham Health from 1.19 at a BMI of 21–22.9 kg/m2 to 3.56 Study that excess body weight may account for up at a BMI 429 kg/m2.33,45 The Asia-Pacific Cohort to 26% of cases of hypertension in men and 28% Collaboration Study, involving 4300 000 adults followed up for almost 7 years, found a 9% increase Not only is obesity linked with hypertension, in ischaemic-heart disease events for each unit but weight loss in obese subjects is associated with change in BMI.46 In addition, obesity was associated a decline in blood pressure.35 In a 4-year follow-up with both fatty streaks and raised atherosclerotic of 181 overweight hypertensive patients, a 10% lesions in the right coronary and left anterior weight loss was independently associated with a 4.3/3.8 mmHg decrease in 24-h ambulatory blood pressure monitoring.37 A meta-analysis of 25 random- In patients with pre-existing heart disease, ized controlled trials that enrolled nearly 5000 however, the relationship between obesity and participants found that both systolic and diastolic cardiovascular mortality is not as strong. A subgroup blood pressures fell by approximately 1 mmHg for analysis from the Physicians Health Study compar- each kg weight loss.38 The anti-hypertensive effect ing cardiovascular mortality in men with a BMI of of weight loss is independent of race or gender.39 22.0–24.9 kg/m2 vs. those with a BMI 428 kg/m2, Furthermore, chronic obesity reduces the efficacy did not find a significant increase on multivariate Heart failureThe relationship between obesity and heart failure Obesity is associated with an unfavourable lipid is complex. In the Framingham Study, almost 6000 profile. Lipid abnormalities related to obesity individuals without a history of heart failure (mean include an elevated serum concentration of choles- age 55 years) were followed for a mean of 14 years.
terol, low-density-lipoprotein (LDL) cholesterol, The risk of developing heart failure was two-fold very low density lipoprotein (VLDL) cholesterol, higher in obese individuals, compared with subjects triglycerides and apolipoprotein B, as well as with a normal body-mass index.45 On multivariate analysis adjusting for risk factors including hyper- (HDL) cholesterol.41 The mechanism(s) underlying tension, coronary artery disease and left ventricular this dyslipidaemia are not fully understood but hypertrophy, there was an excess risk of 5% in men involve the combination of insulin resistance and and 7% in women for each 1 point increase in BMI.
hyperinsulinaemia stimulating hepatic triglyceride It was estimated that 11% of the cases of heart synthesis from an increased adipose tissue under- going enhanced lipolysis. This leads to postprandial hypertrigyceridaemia, smaller and denser LDL Individuals with obesity have a form of cardio- myopathy attributed to chronic volume overload, In a comprehensive meta-analysis, weight loss increased left ventricular wall stress and compensa- of 1 kg decreased serum total cholesterol by 0.05 mmol/l and LDL cholesterol by 0.02 mmol/l, studies have reported abnormal diastolic func- and increased HDL cholesterol by 0.009mmol/l.42 tion50,51 without abnormal systolic function.52,53 Recently, however, in a study comparing the of 11% for ischaemic stroke was found for each transthoracic echocardiography findings of the 1 point increase in BMI.69 In the Physicians Health heart of overweight or obese subjects with non- Study of 21 414 US physicians, those with a BMI obese controls, subtle changes in systolic function 530 kg/m2 had a relative risk of 1.95 for an were observed in parameters such as myocardial ischaemic stroke and 2.25 for a haemorrhagic velocity and strain index even when conventional stroke. Each 1 point increase in BMI resulted in a 2D echo found a normal ejection fraction.54 These 6% increase in the relative risk for total stroke.65 In changes were more prominent in the patients who a study from Sweden of 7402 apparently healthy had a BMI 435 kg/m2, compared to the less obese men aged 47–55 years, followed up over a 28-year patients. Similar findings have been reported in period, BMI 430 kg/m2 resulted in a hazard ratio obese young women (21–37 years of age).55 of 1.78 for ischaemic stroke, but not haemorrhagic Elevated BMI, however, appears to be associated stroke.64 In these studies, the increased risk for with an improved survival in patients with con- stroke persisted, although attenuated, after adjusting gestive heart failure (CHF).56 In the large Digitalis for concomitant risk factors such as hypertension, Obese women also have an increased risk for (BMI 430 kg/m2) had a mortality hazards ratio of stroke. Data from the Women’s Health Study of 0.88 compared to a control group of BMI 18.5–24.9 39 053 women with self-reported weight and height, on multivariate analysis. This has been termed the found a hazards ratio of 1.72 for ischaemic stroke in women with BMI 430 kg/m2 compared to thosewith BMI <25 kg/m2.70 There was no significant relationship between BMI and haemorrhagic stroke.
As noted above, obesity is linked to hypertension, Similar results were found in 116 759 women in coronary artery disease, diabetes mellitus, left the Nurses’ Health Study.67 In this study there was ventricular hypertrophy, left atrial enlargement and a non-significant inverse relationship between CHF. Hypertension, left atrial enlargement and obesity and haemorrhagic stroke. It is unclear why congestive heart failure are all strongly linked to there is no relationship between haemorrhagic atrial fibrillation (AF).57,58 Despite the close relation- stroke and obesity, but it may be linked to the ship between obesity and several of the risk factors lower number of cases in each of the trials, for AF, a clear relationship between AF and obesity has only recently been established. Previous However, not all studies have shown an associa- epidemiologic studies produced conflicting results tion between BMI and stroke,71,72 and recent data as to whether AF is linked to obesity. This may be suggest that central fat accumulation is a stronger due to short-term follow-up, failure to account risk factor for stroke than overall obesity. In a report for interim cardiovascular events and/or lack of from the Israeli Ischemic Heart Disease Study of 9151 male civil servants, trunk body fat was a Data from the Framingham Heart Study62 show predictor of stroke mortality, independent of BMI, a correlation between the risk of developing AF and blood pressure, smoking, socioeconomic status and BMI. In multivariate analysis, adjusting for interim myocardial infarction or heart failure, every increaseof 1 point in BMI was associated with a 4% increase in the risk of AF. In addition, there was a gradual increase in left atrial size as BMI increased. The Obesity is a major risk factor for obstructive sleep relationship between BMI and AF was not significant apnoea (OSA). Over 75% of patients with OSA are after adjusting for left atrial diameter, suggesting reported to be 4120% of ideal body weight.74 a physiological link between obesity and left atrial Epidemiological evidence from the Wisconsin diameter. In addition there is an association Sleep Cohort Study showed that sleep apnoea between obstructive sleep apnoea and AF,63 and risk increased significantly with obesity.75 A neck as will be discussed below, obesity and obstructive circumference 417 inches, which is correlated with obesity, has also been highly correlated with OSA.76,77 In addition, mild-to-moderate weightloss can substantially improve sleep apnoea.79 Obesity is linked to an increased risk of stroke in Obesity probably contributes to OSA via multiple both men and women.64–69 In a study of 234 863 mechanisms. Increased fat deposits in tissues Korean men aged 40–64 years, an adjusted hazard surrounding the upper airway in obese patients may directly impinge on the airway lumen.80 large population-based studies did not find any Upper-body fat deposits may increase airway collapsibility and interfere with the function of the Several studies have examined the relationship inspiratory and expiratory muscles that maintain between GORD and oesophageal erosions. Three airway calibre. Upper airway collapsibility also reported a moderate positive association,98–100 one decreases after weight loss in obese patients reported no association,101 and one found a positive association in women but not in men.102 In a recentstudy in 453 patients, obese patients were 2.5 times as likely as patients with a BMI <25 kg/m2 to have The prevalence of asthma is increased in overweight either reflux symptoms or oesophageal erosions.103 subjects,82 and obese or overweight subjects Since there is a link between GORD and oesoph- account for 75% of emergency department visits ageal adenocarcinoma, the connection between for asthma.83 Longitudinal studies indicate that GORD and obesity deserves further investigation.
obesity antedates asthma, and that the relative risk A recent meta-analysis found a significant associa- of incident asthma increases with increasing tion between obesity and the risk for GORD obesity.84,85 In addition, morbidly obese asthmatic symptoms, erosive oesophagitis and oesophageal subjects studied after weight loss demonstrate decreased severity of asthma symptoms.85 Obesityalso appears to be a risk factor for airway hyper- responsiveness.86 The relationship between obesityand asthma is underlined by the finding that obesity Obesity is associated with cholelithiasis. In the is a strong predictor of the persistence of childhood Nurses’ Health Study, women with BMI <24 kg/m2 asthma into adolescence.5 Potential mechanisms had an incidence of symptomatic gallstones of for this relationship include obesity-related changes approximately 250 per 100 000 person-years of in lung volumes, systemic inflammation and other follow-up.105 Women with BMI 445 kg/m2 had a adipocyte-derived factors that might alter airway seven-fold increase in risk for gallstones compared smooth muscle function and promote airway to women with BMI <24 kg/m2. Women with BMI 430 kg/m2 had a yearly gallstone incidence of Recently, the relationship between respiratory 41% and those with BMI 545 kg/m2 had a rate function and obesity has been examined in the of approximately 2% per year. Similar data were EPIC-Norfolk cohort in Norfolk, UK.88 This group found in men in the Health Professionals Study.34 included 9674 men and 11 876 women aged 45–79 Notably however, there is an increased risk for cholelithiasis in patients who lose weight rapidly.
correlated across the entire spectrum of the waist- Gallstone formation after bariatric surgery has been hip ratio in both men and women, and this relation reported to affect about 38% of patients.106 persisted after adjustment for BMI. This suggeststhat abdominal obesity may impair respiratory Non-alcoholic fatty liver disease (NAFLD) function, and more so than generalized obesity.
NAFLD is increasing in prevalence in developed Furthermore, a post-hoc analysis of a database countries, and is one of the most common causes of four previous placebo-controlled studies of of cryptogenic cirrhosis. It is strongly linked to the monteleukast or inhaled beclomethasone, showed metabolic syndrome, of which obesity is a central a lower placebo response and also a lower response component, and is in fact regarded as the hepatic to inhaled corticosteroid, with increasing BMI, manifestation of the metabolic syndrome.107,108 whereas response to monteleukast was not affected NAFLD is a spectrum of diseases ranging from simple steatosis to steatohepatitis and cirrhosis, with all of its concomitant complications. Patientswith NAFLD especially those with mainly steatosis, respond favourably to weight reduction, and a Gastrooesophageal reflux disease (GORD) is a recent large study showed that achieving 55% common disorder that has been linked to obesity.
weight reduction by lifestyle modifications was Most population-based studies supported this asso- associated with improvement and even normal- ciation in studies conducted in the US, UK, ization of liver enzymes in subjects with impaired Norwegian and Spanish populations,90–95 and two of these studies showed a gradual increase in GORD Interestingly, waist–hip ratio is an independent symptoms as BMI increased.90,91 However, two predictor of advanced fibrosis at liver biopsy.110 in the USA could account for 14% of all cancerdeaths in men and 20% in women.
There is a marked increase in osteoarthritis in the In a systematic review and meta-analysis from the obese. It is most common in the knees and the Comparative Risk Assessment Project evaluating ankles, which may be a consequence of trauma data on 7 million deaths from cancer, 2.43 million related to the excess body weight. In a study of over were attributable to potentially modifiable risk 1000 women, the age-adjusted odds ratio of factors, including overweight and obesity. For every risk factor, they calculated the population knee, as determined by X-ray, was 6.2 for BMI attributable fraction (PAF), estimating the propor- <23.4 kg/m2 and 18 for BMI 426.4 kg/m2. When tional reduction in cancer death if the risk factor was BMI <23.4 kg/m2 was compared to BMI 23.4– reduced. The corresponding PAF for over-weight 26.4 kg/m2, the odds ratios for osteoarthritis were and obesity was: 11% for colon and rectum cancers; increased: 2.9 fold for the knee, 1.7 fold for 5% for breast cancer; 40% for uterine cancer.116 carpometacarpal joint, 1.5 fold for the distal In the Nurses’ Health Study, obesity and weight interphalangeal joint, and 1.2 fold for the proximal gain had differing effects on the risk of breast cancer interphalangeal joint.111 A co-twin control study in premenopausal and postmenopausal women.117 noted that each one kg increase in weight was Premenopausal women with BMI 426 kg/m2 had associated with an increased risk of radiographic lower mortality from breast cancer. In addition, features of osteoarthritis at the knee and carpo- weight gain after the age of 18 years was not associated with increased risk of breast cancer Not only is obesity associated with osteoarthritis, before menopause, but was a risk factor after but weight loss is associated with a decreased risk menopause. In postmenopausal women who had of osteoarthritis. A study of 800 women showed never taken oestrogen hormone replacement ther- that a decrease in BMI of 2 kg/m2 or more in the apy, the relative risk of developing breast cancer preceding 10 years decreased the odds for devel- was 1.6 if they had gained 10–20 kg and 2.0 if they oping osteoarthritis by 450%.113 This benefit was had gained 420 kg, compared to women with also present in those women with a BMI 425 kg/m2 minimal weight gain. Women who were taking and thus at high risk of osteoarthritis.
oestrogen, however, did not have an increased risk The fact that osteoarthritis occurs more frequently of breast cancer associated with weight gain.
in non-weight-bearing joints suggests there are The data suggesting that obesity is one of the components of the obesity syndrome that alter causes for cancer are derived mainly from epide- cartilage and bone metabolism independent of miological studies, which cannot prove cause-effect relationship, and may be confounded by selectionbias. There are also limited data clarifying the underlying mechanisms for this association. It ispossible that the increased production of oestrogens The WHO International Agency for Research on by adipose tissue stromal cells, together with the Cancer has estimated that overweight and inactivity decrease of sex-steroid-binding globulin, is respon- account for from a quarter to a third of all cancers sible for the increased risk of endometrial and of the breast, colon, endometrium, kidney and perhaps breast cancer. Insulin resistance and increased levels of insulin-like growth factor-I Obesity also increases the likelihood of dying (IGF-I) may play a role in colon neoplasm.118–120 from cancer. A 16-year prospective study of Further studies evaluating the possible interaction between genetic background and obesity in the relative risk of death from cancer of 1.5 for men and development of specific type of cancers, are needed.
1.6 for women in the group with BMI 440 kg/m2 vs.
Obesity may also unfavourably influence the BMI 18.5–24.9 kg/m2.115 For both men and women, diagnosis of cancer and the response to therapy.
increasing BMI was associated with higher death The commonly accepted dose reduction of chemo- rates due to cancers of the oesophagus, colon and therapy in the obese may be deleterious. A review of rectum, liver, gallbladder, pancreas, kidney, non- four trials of treatment for breast cancer with a total of 2443 patients in whom the BMI was known, Men were also at increased risk for death from showed that obese patients received a lower dose stomach and prostrate cancer, while women were at of chemotherapy and had a worse outcome in the increased risk of death from cancers of the breast, group with oestrogen-receptor-negative tumours but cervix, uterus and ovary. On the basis of these data, not in the group with oestrogen-receptor-positive the authors estimated that overweight and obesity Obesity in the past was seen as a sign of wealth and In the light of the previously mentioned pulmonary wellbeing. This remains the case in many parts of changes associated with obesity, one might expect Africa, partly as a result of the HIV epidemic and its obesity to be a risk factor for post-operative associated wasting. However, in affluent countries there is a stigma associated with obesity in areas inconsistent. A review of ten series of obese patients such as education, employment and health care.
A survey of more than 10 000 adolescents found a similar 3.9% rate of post-operative pneumonia that women with a BMI above the 95th percentile and atelectasis to that in the general population.131 for age and sex completed fewer years of school In a prospective study of 117 patients undergoing (0.3 years), were 20% less likely to be married, thoracic surgery, there was no difference in the rate had lower household incomes and higher rates of of pulmonary complications when the patients household poverty compared to women who had were stratified by BMI.132 Contrasting findings not been overweight, independent of their baseline were found in a prospective study of 1000 patients socioeconomic status and aptitude test scores.122 undergoing laparotomy, in which BMI 425 kg/m2 Men who had been overweight were less likely to was an independent risk factor for postoperative pulmonary complications.133 Furthermore, in a In a group of 294 patients seeking consultation for prospective study of 400 patients undergoing bariatric surgery, half the patients had a psychiatric abdominal surgery, BMI 427 kg/m2 was one of six disorder and 29% had comorbidity. The highest prevalence rates were 29% for somatization, 18% tions.134 One possible explanation for the differ- for social phobia, 155 for hypochondriasis and 14% ences between these reports may be failure to distinguish between obesity and other comorbid In addition, eating disorders such as binge eating conditions. In a prospective study of 272 patients disorder and night eating syndrome have been referred for medical evaluation prior to non-thoracic surgery, using explicit criteria for postoperativepulmonary complications, the odds ratio was 4.1for patients with BMI 430 kg/m2, but this was no longer significant under multivariate analysis.135 A review of six studies encompassing a total of4536 patients found a similar risk of pulmonary Obesity during pregnancy is associated with an complications for both obese and non-obese gestational diabetes, pre-eclampsia, and deliverycomplications dystocia and higher rates of caesarean sections and infections. Maternal obesity may also be an The epidemic of obesity in the developed world has independent risk factor for neural tube defects and been associated with an increase in the prevalence fetal mortality. This subject has been reviewed of chronic kidney disease. It is however, unclear whether obesity is a risk factor independent of Obesity is now estimated to be responsible for 6% of primary infertility.126 In men, there is a link Among NHANES III participants, the risk of either between impotence and increasing infertility, with incident end-stage renal disease or kidney-related abdominal obesity a particular risk.127,128 death was independently associated with a BMI Polycystic ovary syndrome (PCOS), the most 435 kg/m2, with a relative risk of 2.3 among those common endocrine disorder in women of repro- morbidly obese compared with normal weight ductive age, is characterized by a combination of persons, but risk was not increased for those chronic anovulation, polycystic ovary morphology classified as overweight or obese.138 In the and hyperandrogenism.129 Obesity and insulin Framingham study, patients who were obese at resistance are closely related with PCOS, and insulin baseline were more likely to have a decrease in resistance has a pivotal role in the pathogenesis of estimated glomerular filtration rate (GFR).139 Under this syndrome. Women with PCOS respond favour- multivariate analysis, increased baseline BMI was ably to weight loss, as well as to pharmacological significantly associated with progression to chronic treatment of insulin resistance, with decrease in kidney disease, with an odds ratio of 1.23 for each Notably, weight loss may preserve renal function.
syndrome, a cluster of abnormalities related to In a study of 24 type 1 and type 2 diabetics insulin resistance,153 was also associated with with nephropathy, a reduction in BMI from 33 increased risk of developing type 2 DM and CVD to 26 kg/m2 was associated with a decrease in large prospective studies.154–156 Population- in proteinuria from 1.3 to 0.623 g per 24 h, attributable risk estimates associated with the meta- bolic syndrome were 34%, 29% and 62% in men, and 16%, 8% and 47% in women, for CVD, CHD,and type 2 DM, respectively.157 The metabolicsyndrome includes known risk factors for CVD such as abdominal obesity, hypertension, glucose intolerance, high triglycerides and low HDL-cholesterol. In addition, some data suggest that Despite the mortality and morbidity associated with even after adjusting for these known risk factors, obesity described in previous sections, clinicians are the metabolic syndrome remains an independent well aware of the phenomenon of the healthy obese risk factor for CVD.158,159 Obese and overweight individual. Therefore, further characteristics that will people tend to be more insulin-resistant, yet only identify subsets of obese high-risk patients vs. obese about half have significant insulin resistance.160 Identifying obese insulin-resistant individuals indaily practice is of great importance, since weight reduction is especially beneficial in reducing CVD Several studies have shown that low physical fitness risk factors in this sub-group.160,161 Fortunately, and physical activity are independent predictors insulin resistance can be identified by relatively for all-cause mortality, CVD mortality and cardio- simple measures such as high fasting serum vascular events in lean and obese men and insulin levels or by high triglycerides and low women.141–144 In the Aerobics Center Longitudinal Study, unfit lean men had a higher risk for all-cause Obesity has been associated with increased risk and CVD mortality than men who were fit and of several types of commonly occurring cancer, obese.142 In a long-term prospective study of Finnish as noted above. In addition, obesity is associated men and women, low leisure time physical activity with both a higher rate of recurrence of breast and physical fitness, but not high BMI, were cancer and a worse prognosis.161 Interestingly, predictors of all-cause and CVD mortality.145 abdominal obesity and insulin resistance were However in another study conducted in men and shown to be associated with some types of cancer women, physical fitness, although associated with such as colon and breast neoplasia, suggesting that reduced mortality from CVD, did not completely one of the mechanisms linking obesity and cancer reverse the increased risk associated with obesity.146 is related to insulin-like growth factors.118–120 One of the mechanisms by which increasedphysical activity and fitness can reduce CVD risk and all-cause mortality is by modulating insulin The recently published INTERHEART study exam- sensitivity. In both Caucasians and Pima Indians, ined the predictive value for myocardial infarction maximal aerobic capacity is positively correlated of different obesity markers in427 000 subjects from with insulin action.147 Other protective mechanisms different ethnic groups, in 52 countries.162 It found of physical activity include: improvement of blood that waist–hip ratio was superior to BMI, having a pressure, atherogenic dyslipidaemia and inflam- graded and significant association with myocardial infarction that persisted after adjusting for the other function.148 The protective role of physical exercise known risk factors. BMI, in contrast, showed only a and fitness implies that physicians should at leastobtain a self-record of physical activity and fitness modest association, in some but not all populations, as part of assessing the risks associated with obesity.
and the association was not significant after furtheradjustments. This study confirms (and extends to different populations) the results of previous studies, showing that simple measures of waist or waist–hipratio are closely related with CVD risk.163–165 Insulin resistance and the compensatory hyper- insulinemia, are strongly associated with increased increased visceral adipose tissue known to be risk for type 2 diabetes, CVD and CHD mortality in more metabolically active, releasing free fatty large epidemiological studies.149–152 The metabolic to insulin resistance.166 In a study comparing Table 1 Obesity-associated complications that respond removal of 1 kg visceral fat at bariatric surgery with bariatric surgery alone, there was a significantimprovement in insulin sensitivity in those patients while removal of subcutaneous tissue had no effect on insulin sensitivity.168 Therefore, assessment of visceral fat accumulation by measuring waist–hip ratio should be part of the routine assessment of The gene-environment interaction is known to playa role in multiple diseases. Obesity is associated NAFLD, non-alcoholic fatty liver disease.
with many comorbidities, and an interactionbetween obesity and a positive family history hasbeen shown in several of these associated illnesses.
data describing a U-shaped association, with excess In individuals with a strong family history of diabetes mortality in both under-weight and severe obesity, and increased BMI, reduced beta-cell compensation while milder degrees of overweight do not show to the insulin resistance associated with obesity was increased rates. In addition, improved standards of found, increasing the risk for developing type 2 medical care may attenuate the effect of obesity on diabetes.169 BMI was strongly associated with breast life expectancy. The economic burden of providing cancer risk among women with a strong family this medical care to increasing numbers of obese history of breast cancer, but only weakly associated subjects cannot however be dismissed.
in those women without a family history.170 In Not all obese patients will develop complications.
women with a family history of premature coronary Further characterization of physical activity and artery disease, BMI was an independent predictor fitness, fat distribution, insulin resistance and family of coronary artery calcification.171 Further studies history of obesity-related diseases, can identify the are needed to elucidate the possible interactions obese person who is at increased risk. The age of between obesity and genetic background, but onset of obesity also needs to be taken into account, obtaining a family history may be helpful in as the life-long risk of developing obesity-related assessing the risk of the individual obese patient.
complications is higher in early-onset comparedwith late-onset obesity.
We suggest the following scheme for the manage- ment of the patient with obesity. Firstly, for patients Obesity is linked with a large range of medical who suffer from obesity-related complications complications. There is evidence that obesity is not listed in Table 1 that have been shown to respond only related to conditions such as diabetes, hyper- favourably to weight loss, we recommend that tension, heart disease, obstructive sleep apnoea, dietary consultation be part of the treatment plan.
asthma, non-alcoholic fatty liver disease, osteo- Secondly, since not all obese subjects will arthritis and polycystic ovary syndrome, but also develop associated morbidities, we list clinical that weight reduction has beneficial effects and characteristics that are of assistance in identifying therefore is an integral part of treating these those asymptomatic obese people who have a morbidities (Table 1). Although there is a significant particularly high risk for developing obesity-related association between certain types of cancer and complications (Table 2). The rationale of focusing obesity, the inherent limitation of epidemiological the effort to achieve weight reduction in this high- studies in establishing causality, together with the risk group, is based on data from studies such as lack of intervention studies, underline the need for the large Diabetes Prevention Program, in which further studies before the role of obesity in cancer is 3234 non-diabetic overweight or obese patients with elevated glucose levels were randomized Another controversial issue is the association to placebo, lifestyle modification program or metformin. The lifestyle modification program was researchers believe that obesity will shorten the life aimed at achieving 7% weight loss and 150 min of expectancy of obese populations, there are other physical activity per week. This program lasted for 2. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL.
Table 2 Clinical characteristics of the ‘high-risk’ obese Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes 1998; 22:39–47.
3. International Agency for Research on Cancer, World Health Abdominal obesity (increased waist–hip ratio) Organization.2002 Weight control and physical activity. In: Vainio H, Bianchini F, eds. International Agency for High triglycerides and low HDL-cholesterol levels Research on Cancer handbooks of cancer prevention, vol 6. Lyon, France, IARC Press, 2002.
implications in lower-income countries. Public Health Nutr 5. Drenick EJ, Bale GS, Seltzer F, Johnson DG. Excessive mortality and causes of death in morbidly obese men. JAMA 6. Build and Blood Pressure Study, 1959. Chicago, Society of 7. Keys A. Seven countries: a multivariate analysis of death 3 years, and resulted in a 58% reduction in diabetes and coronary heart disease. Cambridge MA, Harvard For morbidly obese persons with a high-risk 8. Waaler HT. Height, weight and mortality: the Norwegian profile or the above-mentioned complications, experience. Acta Med Scand Suppl 1984; 679:1–56.
who fail to lose weight, pharmacological adjunct 9. Build Study, 1979. Chicago, Society of Actuaries and therapy and bariatric surgery should be considered.
association of Life Insurance Medical Directors of America, This is supported by the results of two large intervention studies with a relatively long-term 10. Lew EA, Garfinkel L. Variations in mortality by weight among follow up. In the first, a randomized trial comparing 750,000 men and women. J Chronic Dis 1979; 32:564–76.
combined dietary intervention with orlistat (lipase 11. Lee IM, Manson JE, Hennekens CH, Paffenbarger RS. Body inhibitor) and dietary intervention to dietary inter- weight and mortality: a 27 year follow-up of middle-aged vention alone, the combined therapy given for 4-year period, resulted in a 37% reduction in the 12. Lindsted K, Tonstad S, Kazma JW. Body mass index and incidence of diabetes due to the effect in a subgroup patterns of mortality amongst Seventh-day Adventist men.
Int J Obes 1991; 15:397–406.
of patients with impaired glucose tolerance.173In the second large study, 1703 obese patients 13. Wilcosky T, Hyde J, Anderson JJB, Bangdiwala S, Duncan B.
Obesity and mortality in the Lipid Research Clinic Program who underwent bariatric surgery were followed for Follow-Up Study. J Clin Epidemiol 1990; 43:743–52.
10 years, and compared to conventionally treated 14. Vandendbroucke JP, Mauritz BJ, deBruin A, Verheesen JH, obese subjects. The surgery group lost significantly van der Heide-Weisel C, van der Heide RM. Weight, more weight and maintained the weight loss smoking and mortality. JAMA 1984; 252:2859–60.
throughout the follow-up period and this weight 15. Menotti A, Descovich GC, Lanti M, Spagonolo A, Dormi A, loss was accompanied by a significantly lower Seccareccia F. Indexes of obesity and all causes mortality in incidence of diabetes and hypertriglyceridemia.174 Italian epidemiology data. Prev Med 1993; 22:293–303.
The issues of safety, cost-effectiveness and quality 16. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, of life, related to pharmacological and surgical Hankinson SA, et al. Body weight and mortality among therapies for obesity, are still debated, and an women. N Engl J Med 1995; 333:677–85.
individual approach has been suggested.175 Before 17. Gu D, He J, Duan X, Reynolds K, Wu X, Chen J, Huang G, establishing definite treatment guidelines, more et al. Body weight and mortality among men and women inChina. JAMA 2006; 295:776–83.
large intervention studies, focusing on differentage groups and obesity-related comorbidities are 18. Bradley PJ. Is obesity an advantageous adaptation? Int J Obes needed to address the long-term cost-effectivenessand quality of life associated with various treatment 19. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a casecontrol study. Lancet 2005; 366:1640–9.
20. Keys A, Fidanza P, Karvonen MJ, Kimura N, Taylor AL.
Indices of relative weight and obesity. J Chronic Dis 1972; 1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence 21. Revicki DA, Israel RG. Relationship between body mass and trends in obesity among US adults, 1999–2000. JAMA indexes and measures of body adiposity. Am J Public Health 22. Kvist H, Chowdhury B, Grangard U, Tylen U, Sjostrom L.
38. Neter JE, Stam BE, Kok FJ, Grobbee DE. Influence of weight Total and visceral adipose-tissue volumes derived from reduction on blood pressure: a meta-analysis of randomized measurements with computed tomography in adult men controlled trials. Hypertension 2003; 42:878–84.
and women: predictive value. Am J Clin Nutr 1988; 39. Stevens VJ, Corrigan SA, Obarzenak E, Bernauer E, Cook NR, Hebert P, et al. Weight loss intervention in phase 1 trials of 23. Lissner L, Odell PL, D’Agostino RB, Stokes J 3rd, Kreger BE, Hypertension prevention. The TOHP collaborative research Belanger AJ, et al. Variability of body weight and health group. Arch Intern Med 1993; 153:849–58.
outcomes in the Framingham population. N Engl J Med 40. Modan M, Almog S, Fuchs Z, Chetrit A, Lusky A, Halkin H.
24. Diaz VA, Mainous AG III, Everett CJ. The association response to antihypertensive drugs. Hypertension 1991; between weight fluctuation and mortality: results from a population-based cohort study. J Community Health 2005; 41. Grundy SM, Barnett JP. Metabolic and health complications of obesity. Dis Mon 1990; 36:641–731.
25. Flegal KM, Graubard KI, Williamson DF, Gail MH. Excess 42. Datillo AM, Kris-Etherton PM. Effects of weight reduction on deaths associated with underweight, overweight and obesity.
blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 26. National Center for Health Statistics. Health, United States, 43. Krauss RM, Winston M. Obesity: impact on cardiovascular 2005 With Chartbook on Trends in the Health of Americans.
disease. Circulation 1998; 98:1472–6.
Hyatsville MD, National Center for Health Statistics, 2002.
Available at ].
44. Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, et al. Weight, weight change and coronary heartdisease in women. Risk within the ‘normal’ weight range.
Williams DE, Flegal KM, et al. Secular trends in cardio-vascular disease risk factors according to body mass index in 45. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, US adults. JAMA 2005; 293:1868–74.
Larson MG, et al. Obesity and the risk of heart failure. N EnglJ Med 2002; 347:305–13.
28. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women.
46. James WPT, Jackson-Leach R, Ni Mhurvhu, Kalamara E, Shayeghi M, Rigby NJ, et al. Overweight and obesity (high body mass index). In: Ezzati M, Lopez AD, Rodgers A, 29. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC.
Murray CJL, eds. Comparative quantification of health risks: Obesity and fat distribution and weight gain as risk factors global and regional burden of disease attributable to selected for clinical diabetes in men. Diabetes Care 1994; 17:961–9.
major risk factors, vol. 1. Geneva, WHO, 2004:497–596.
30. Knowler WC, Pettitt DJ, Saad MF, Charles MA, Nelson RG, 47. McGill HC , Jr, McMahan CA, Herderick EE, Zieske AW, Howard BV, et al. Obesity in the Pima Indians: its Malcom GT, Tracy RE, et al. Obesity accelerates the magnitude and relationship to diabetes. AmJ Clin Nutr progression of coronary atherosclerosis in young men.
31. Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, 48. Widlansky ME, Sesso HD, Rexrode KM, Manson JE, Shochat T, et al. Normal fasting plasma glucose levels Gaziano M. Body mass index and total and cardiovascular and type 2 diabetes in young men. N Engl J Med 2005; mortality in men with a history of cardiovascular disease.
Arch Intern Med 2004; 164:2326–32.
32. Sjostrom CD, Lissner L, Wedel H, Sjostrom L. Reduction in 49. Alpert MA. Obesity cardiomyopathy: pathophysiology and incidence of diabetes, hypertension and lipid disturbances evolution of the clinical syndrome. Am J Med Sci 2001; after interventional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999; 7:477–84.
50. Chakko S, Alpert MA, Alexander JK. Obesity and ventricular 33. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, function in man: diastolic function. In: Alpert MA, Bouchard C, Carlsson B, et al. Lifestyle, diabetes and Alexander JK, eds. The Heart and Lung in Obesity.
cardiovascular risk factors 10 years after bariatric surgery.
51. Zarich SW, Kowalchuk GJ, McGuire MP, Benotti PN, 34. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy Mascioli EA, Nesto RW. Left ventricular filling abnormalities in asymptomatic morbid obesity. Am J Cardiol 1991; 35. Huang Z, Willett WC, Manson JE, Rosner B, Stampfer MJ, Speizer FE, et al. Body weight, weight change and risk for 52. Pascual M, Pascual DA, Soria F, Vicente T, Hernandez AM, hypertension in women. Ann Intern Med 1998; 128:81–8.
Tebar FJ, et al. Effects of isolated obesity on systolic and diastolic left ventricular function. Heart 2003; 89:1152–6.
Kannel WBl. Overweight and obesity as determinants of cardiovascular risk; the Framingham experience. Arch Intern Ganguzza A, Parrinello G, et al. Left ventricular diastolic and systolic function in normotensive obese subjects: 37. Schillaci G, Pasqualini L, Vaudo G, Pirro M, Gemelli F, influence of degree and duration of obesity. Eur Heart J De Sio M, et al. Effect of body weight changes on 24-hour blood pressure and left ventricular mass; a 4-year follow-up.
54. Yong CY, O’Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alteration of left ventricular myocardial characteristics associated with obesity. Circulation 2004; and risk of stroke in apparently healthy women. Circulation 55. Peterson LR, Waggoner AD, Schechtman KB, Meyer T, 71. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjontorp P, Gropler RG, Barzilai B, et al. Alterations in left ventricular Tibblin G. Abdominal adipose tissue distribution, obesity structure and function in young healthy obese women.
and risk of cardiovascular disease and death: 13 year follow Assessment by echocardiography and tissue Doppler imag- up of participants in the study of men born in 1913. Br Med J ing. J Am Coll Cardiol 2004; 43:1399–404.
56. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, 72. Walker S, Rimm E, Ascherio A, Kawachi I, Stampfer M, Jadbabaie F, et al. The obesity paradox. Body mass index Willet W. Body size and fat distribution as predictors of and outcomes in patients with heart failure. Arch Intern Med stroke among US men. Am J Epidemiol 1996; 144:1143–50.
73. Tanne D, Medalie JH, Goldbourt U. Body fat distribution and 57. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, long-term risk of stroke mortality. Stroke 2005; 36:1021–5.
Selby JV, et al. Prevalence of diagnosed atrial fibrillation in 74. Kales A, Cadieux RJ, Bixler EO, Soldatos CR, Vela-Bueno A, adults: national implications for rhythm management and Misoul CA, et al. Severe obstructive sleep apnea-I:onset, stroke prevention: the anticoagulation and risk factors in clinical course and characteristics. J Chronic Dis 1985; atrial fibrillation (ATRIA study). JAMA 2001; 285:2370–5.
58. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, 75. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S.
Wolf PA. Independent risk factors for atrial fibrillation in The occurrence of sleep-disordered breathing among a population-based cohort: the Framingham Heart Study.
middle-aged adults. N Engl J Med 1993; 328:1230–5.
76. Davies RJO, Ali NJ, Stradling JR. Neck circumference and 59. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE.
other clinical features in the diagnosis of the obstructive The natural history of atrial fibrillation: incidence, risk factors sleep apnoea syndrome. Thorax 1992; 47:101–5.
and prognosis in the Manitoba follow-up study. Am J Med1995; 98:476–84.
77. Katz I, Stradling J, Slutsky AS, Zamel N, Hoffstein V.
Do patients with obstructive sleep apnea have thick necks? 60. Ruigomez A, Johansson S, Wallander MA, Rodriguez LA.
Am Rev Respir Dis 1990; 141:1228–31.
Incidence of chronic atrial fibrillation in general practice andits treatment pattern. J Clin Epidemiol 2002; 55:358–63.
78. Smith PL, Gold AR, Meyers DA, Haponik EF, Bleecker ER.
Weight loss in mildly to moderately obese patients 61. Wilhelmsen L, Rosengren A, Lappas G. Hospitalizations of with obstructive sleep apnea. Ann Intern Med 1985; atrial fibrillation in the general male population : morbidity and risk factors. J Intern Med 2001; 250:382–9.
62. Wang TJ, Parise H, Levy D, D’Agostino RB Sr, Wolf PA, Burman ED, Longmore DB. Sites and sizes of fat deposits Vasan RS, et al. Obesity and the risk of new-onset atrial around the pharynx in obese patients with obstructive sleep fibrillation. JAMA 2004; 292:2471–7.
apnoea and weight matched controls. Eur Respir J 1989; 63. Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and 80. Schwartz AR, Gold AR, Schubert N, Stryzak A, Wise RA, obstructive sleep apnea. Circulation 2004; 110:364–7.
Permutt S, et al. Effect of weight loss on upper airway 64. Jood K, Jern C, Wilhelmsen L, Rosengren A. Body mass index collapsibility in obstructive sleep apnea. Am Rev Respir Dis in mid-life is associated with a first stroke in men: a prospective population study over 28 years. Stroke 2004; 81. Weiss ST, Shore S. Obesity and asthma: directions for research. Am J Respir Care Med 2004; 169:963–8.
65. Kurth T, Gaziano JM, Berger K, Kase CS, Rexrode KM, 82. Thomson CC, Clark S, Camargo CA Jr. Body mass index and Cook NR, et al. Body mass index and the risk of stroke in asthma severity among adults presenting to the emergency men. Arch Intern Med 2002; 162:2557–62.
department. Chest 2003; 124:795–802.
66. Suk SH, Sacco RI, Boden-Albala B, Cheun JF, Pittmann JG, 83. Canargo CA Jr, Weiss ST, Zhang S, Willett WC, Speizer FE.
Elkind MS, Palk MC. Abdominal obesity and risk of ischemic Prospective study of body mass index, weight change and stroke: the Northern Manhattan Stroke Study. Stroke 2003; risk of adult-onset asthma in women. Arch Intern med 1999; 67. Rexrode KM, Hennekens CH, Willet WC, Colditz GA, 84. Guerra S, Wright AL, Morgan WJ, Sherrill DL, Holberg CJ, Stampfer MJ, Rich-Edwards JW, et al. A prospective study Martinez FD. Persistence of asthma symptoms during of body mass index, weight change and risk of stroke in adolescence: role of obesity and age at onset of puberty.
Am J Respir Crit Care Med 2004; 170:78–85.
68. Millionis HJ, Goudevenos J, Seferiadis K, Elisaf MS.
85. Aaron SD, Fergusson D, Dent R, Chen Y, Vandemheen KL, Association between body mass index and risks in elderly Dales RE. Effect of weight reduction on respiratory function patients with a first-ever acute ischemic stroke. Arch Intern and airway reactivity in obese women. Chest 2004; 69. Song YM, Sung J, Davey Smith G, Ebrahim S. Body mass 86. Litonjua AA, Sparrow D, Celedon JC, DeMolles D, index and ischemic and hemorrhagic stroke; a prospective Weiss ST. Association of body mass index with the study in Korean men. Stroke 2004; 35:831–6.
development of methacholine airway hyperresponsive- 70. Kurth T, Gaziano JM, Rexrode KM, Kase CS, Cook NR, ness in men:the Normative Aging Study. Thorax 2002; Manson JE, Buring JE. Prospective study of body mass index 87. Shore SA, Fredberg JJ. Obesity, smooth muscle and 104. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: airway hyperresponsiveness. J Allergy Clin Immunol 2005; obesity and the risk for gastroesophageal relux disease and its complications. Ann Intern Med 2005; 143:199–211.
88. Canoy D, Luben R, Welch A, et al. Abdominal obesity and 105. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, respiratory function in men and women in the EPIC-Norfolk Willett WC. Risk of symptomatic gallstones in women Study, United Kingdom. Am J Epidemiol 2004; 159:1140–9.
with severe obesity. Am J Clin Nutr 1992; 55:652–8.
89. Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response Borges Da Silva B. Impact of rapid weight reduction on to asthma controller agents. Eur Respir J 2006; 27:495–503.
risk of cholelithiasis after bariatric surgery. Obes Surg 2003; 90. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Risk factors associated with symptoms of gastroesopha- 107. Malnick SD, Beergabel M, Knobler H. Non-alcoholic fatty geal reflux. Am J Med 1999; 106:642–9.
liver: a common manifestation of a metabolic disorder.
91. Murray L, Johnston B, Lane A, Harvey I, Donovan J, Nair P.
Relationship between body mass and gastro-oesophageal 108. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, reflux symptoms: the Bristol Helicobacter Project. Int J Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern 92. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J, et al.
Obesity and estrogen as risk factors for gastroesophageal 109. Suzuki A, Lindor K, St Saver J, Lymp J, Mendes F, Muto A, reflux symptoms. JAMA 2003; 290:66–72.
et al. Effect of changes on body weight and lifestyle 93. Delgado-Aros S, Locke GR 3rd, Camilleri M, Talley NJ, in nonalcoholic fatty liver disease. J Hepatol 2005; Fett S, Zinsmeister AR, et al. Obesity is associated with increased risk of gastrointestinal symptoms: A population- 110. Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, based study. Am J Gastroenterol 2004; 99:1801–6.
Reines HD, et al. Predictors of non-alcoholic steatohepatitis 94. Nandurkar S, Locke Gr 3rd, Fett S, Zinsmeister AR, and advanced fibrosis in morbidly obese patients. Obes Cameron AJ, Talley NJ. Relationship between body mass index, diet, exercise and gastroesophageal reflux 111. Hart DJ, Spector TD. The relationship of obesity, fat symptoms in a community. Aliment Pharmacol Ther 2004; distribution and osteoarthritis in women in the general population: The Chingford Study. J Rheumatol 1993; 95. Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, Locke GR 3rd, Rodriguez-Artalejo F. Symptoms of gastro-oesophageal 112. Cicuttini FM, Baker JR, Spector TD. The association of reflux: Prevalence, duration, severity and associated symp- obesity with osteoarthritis of the hand and knee in women: toms in a Spanish population. Aliment Pharmacol Ther a twin study. J Rheumatol 1996; 23:1221–6.
113. Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ.
96. Lagergren J, Bergstrom R, Nyren O. No relation between Weight loss reduces the risk for symptomatic knee body mass and gastro-oesophageal reflux symptoms in a osteoarthritis in women. The Framingham Study. Ann Swedish population-based study. Gut 2000; 47:26–9.
97. Andersen LI, Jensen G. Risk factors for benign oesophageal 114. Vainio H, Bianchini F, eds. International Agency for Cancer disease in a random population sample. J Intern Med 1991; handbook of cancer prevention, vol. 6. Weight control and physical activity. Lyon, IARC, 2002.
98. Wilson LJ, Ma W, Hirshcowitz BI. Association of obesity 115. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ.
with hiatal hernia and esophagitis. Am J Gastroenterol Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 99. Chang CS, Poon SK, Lien HC, Chen GH. The incidence of reflux esophagitis among the Chinese. Am J Gastroenterol 116. Danaei G, Vander Hoorn S, Lopez AD, Murray CJL, 100. Ruhl CE, Everhart JE. Overweight but not high dietary fat collaborating group. Causes of cancer in the world: intake increases risk of gastroesophageal reflux disease comparative risk assessment of nine behavioural and hospitalization: the NHANES I epidemiologic follow up environmental risk factors. Lancet 2005; 366:1784–93.
study. First national health and Nutrition Examination 117. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Survey. Ann Epidemiol 1999; 9:424–35.
Hunter DJ, Manson JE, et al. Dual effects of weight 101. Furukawa N, Iwakiri R, Koyama T, Okamoto K, Yoshida T, and weight gain on breast cancer risk. JAMA 1997; Kashiwagi Y, et al. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy.
118. McTiernan A. Obesity and cancer: the risks, science, J Gastroenterology 1999; 34:441–4.
and potential management strategies. Oncology 2005; 102. Nilsson M, Lundegardh G, Carling L, Ye W, Lagergren J.
Body mass and reflux esophagitis: an oestrogen-dependent 119. Otake S, Takeda H, Suzuki Y, Fukui T, Watanabe S, association? Scand J Gastroenterol 2002; 37:626–30.
Ishihama K, et al. Association of visceral fat accumulation 103. El-Serag HB, Graham DY, Sattia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive evidence for participation of insulin resistance. Clin esophagitis. Am J Gastroenterol 2005; 100:1243–50.
120. Stoll BA. Western nutrition and the insulin resistance 139. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, syndrome: a link to breast cancer. Eur J Clin Nutr 1999; Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291:844–50.
140. Solerte SB, Fioravanti M, Schifino N, Ferrari E. Effects of Castiglione-Gertsch M, Goldhirsch A. Relation between diet-therapy on urinary protein excretion albuminuria and chemotherapy dose, oestrogen receptor expression and renal haemodynamic function in obese diabetic patients body-mass index. Lancet 2005; 366:1108–10.
with overt nephropathy. Int J Obes 1989; 13:203–11.
122. Gortmaker SL, Must A, Perrin JM, Sobol AM, Dietz WH.
Social and economic consequences of overweight in Gibbons LW, Paffenbarger RS Jr, Blair SN. Relationship adolescence and young adulthood. N Engl J Med 1993; between low cardiorespiratory fitness and mortality in normal-weight, overweight and obese men. JAMA 1999;282:1547–53.
123. Rosik CH. Psychiatric symptoms among prospective bariatric surgery patients: rates of prevalence and their 142. Lee CD, Blair SN, Jackson AS. Cardiorespiratory fitness, relation to social desirability, pursuit of surgery, and body composition and all-cause and cardiovascular disease follow-up attendance. Obes Surg 2005; 15:677–83.
mortality in men. Am J Clin Nutr 1999; 69:373–80.
124. Stunkard AJ. Binge-eating disorder and the night-eating 143. Haapanen-Niemi N, Miilunpalo S, Pasanen M, Vuori I, syndrome. In: Wadden TA, Stunkard AJ, eds. Handbook on Oja P, Malmberg J. Body mass index, physical inactivity obesity treatment. Guilford Press, New York, 2002:107–21.
and low level of physical fitness as determinants ofall-cause 125. Dietl J. Maternal obesity and complications during follow-up of middle-aged and elderly men and women.
pregnancy. J Perinat Med 2005; 33:100–5.
Int J Obes Relat Metab Disord 2000; 24:1465–74.
126. Green BB, Weiss NS, Darling JR. Risk of ovulatory infertility 144. Wessel TR, Arant CB, Olson MB. Relationship of physical in relation to body weight. Fertil Steril 1988; 50:721–6.
activity vs. Body mass index with coronary artery disease 127. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, and cardiovascular events in women. JAMA 2004; D’Andrea F, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial.
145. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G.
Relationship between degree of obesity and in vivo insulin 128. Esposito K, Giugliano D. Obesity, the metabolic syndrome, action in man. Am J Physiol 1985; 248:E286–91.
and sexual dysfunction. Int J Impot Res 2005; 17:391–8.
146. Stevens J, Cai J, Evenson KR, Thomas R. Fitness and 129. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus fatness as predictors of mortality from all causes and Workshop Group.Revised 2003 consensus on diagnostic from cardiovascular disease in men and women in criteria and long-term health risks related to polycystic the lipid research clinics study. Am J Epidemiol 2002; ovary syndrome. Fertil Steril 2004; 81:19–25.
130. Ehrmann DA. Medical Progress. Polycystic ovary syndrome.
147. Bassuk SS, Manson JE. Epidemiological evidence for the role of physical activity in reducing risk of type 2diabetes and cardiovascular disease. J Appl Physiol 2005; 131. Pasulka PS, Bistrian BR, Benotti PN, Blackburn GL. The risks of surgery in the obese patients. Ann Intern Med 1986;104:540–6.
148. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ferraro R, Foley JE, Ravussin E, et al. Insulin resistance and 132. Dales RE, Dionne G, Leech JA, Lunau M, Schweitzer I.
insulin secretory dysfunction as precursors of non- insulin dependent diabetes mellitus. N Eng J Med 1993; following thoracic surgery. Chest 1993; 104:155–9.
133. Hall JC, Tarala RA, Hall JL, Mander J. A multivariate 149. Fontbonne AM, Eschwege EM. Insulin and cardiovascular analysis of the risk of pulmonary complications after disease. Paris Prospective Study. Diabetes Care 1991; 134. Brooks-Bunn JA. Predictors of post-operative pulmonary 150. Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K.
complications following abdominal surgery. Chest 1997; Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men. The 135. McAlister FA, Khan NA, Straus SE, Papaioakim M, 22-year follow-up results of the Helsinki Policemen Study.
Fisher BW, Majumdar SR, et al. Accuracy of the Arterioscler Thromb Vasc Biol 2000; 20:538–44.
preoperative assessment in predicting pulmonary risk after nonthoracic surgery. Am J Resp Care Med 2003; Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J 136. Smetana GW. Preoperative pulmonary evaluation. N Engl J 152. Grundy SM, Cleeman JI, Daniel SR, Donato KA, Eckel RH, 137. Wiggins KJ, Johnson DW. The influence of obesity on the Franklin BA, et al. Diagnosis and management of the development and survival outcomes of chronic kidney metabolic syndrome. An American Heart Association/ disease. Adv Chronic Kidney Dis 2005; 1:49–55.
National Heart, Lung, and Blood Institute scientific state- 138. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, ment. Curr Opin Cardiol 2006; 21:1–6.
Brancati FL. Lifestyle factors, obesity and the risk of chronic 153. Laaka HM, Laaksonen DE, Lakka TA, Niskanen LK, kidney disease. Epidemiology 2003; 14:479–87.
Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle- gastric banding. Int J Obes Relat Metab Disord 2002; 154. Malik S, Wong ND, Franklin SF, Kamath TV, L’Italien GJ, 168. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Pio JR, et al. Impact of the metabolic syndrome on mortality Patterson BW, et al. Absence of an effect of liposuction from coronary heart disease, cardiovascular disease, and on insulin action and risk factors for coronary heart disease.
all causes in United States adults. Circulation 2004; 169. Elbein SC, Wegner k, Kahn SE. Reduced beta-cell 155. Wilson PWF, D’ Agostino RB, Parise H, Sullivan L, compensation to the insulin resistance associated with Meigs JB. Metabolic syndrome as a precursor of cardio- obesity in members of caucasian familial type 2 diabetes vascular disease and type 2 diabetes mellitus. Circulation kindreds. Diabetes Care 2000; 23:221–7.
170. Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L. Effect 156. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, of family history, obesity and exercise on breast cancer risk Reaven G. Use of metabolic markers to identify overweight among postmenopausal women. Int J Cancer 2003; individuals who are insulin resistant. Ann Intern Med 2003; 171. Valdes AM, Wolfe ML, Tate HC, Gefter W, Rut A, Rader DJ.
157. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Association of traditional risk factors with coronary Al Mamun A, Bonneux L; NEDCOM, the Netherlands calcification in persons with a family history of premature Epidemiology and Demography Compression of Morbidity coronary heart disease: the study of the inherited risk of Research Group. Obesity in adulthood and its conse- coronary atherosclerosis. J Investig Med 2001; 49:353–61.
quences for life expectancy: a life-table analysis. Ann Intern 172. Knowler WC, Barret-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence 158. Mark DH. Deaths attributable to obesity. JAMA 2005; of type 2 diabetes with lifestyle intervention or metformin.
159. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, 173. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. Xenical Williams DE, Flegal KM, Narayan KM, Williamson DF.
in the prevention of diabetes in obese subjects (XENDOS) study; a randomized study of orlistat as an adjunct tolifestyle changes for the prevention of type 2 diabetes in 160. McLaughlin T, Abbasi F, Kim HS, Lamendola C, Schaaf P, Reaven G. Relationship between insulin resistance, weight loss, and coronary heart disease in healthy, obese women.
174. Sjostrom l, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, andcardiovascular risk factors 10 years after bariatric surgery.
161. Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA. Body mass and mortalityafter breast cancer diagnosis. Cancer Epidemiol Biomarkers 175. Mun WC, Blackburn GL, Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterology2001; 162. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial 176. Avenell A, Broom J, Brown TJ, Poobalan A, Aucott l, infarction in 27000 participants from 52 countries: a case- Stearns SC, et al. Systematic review of the long-term effects control study. Lancet 2005; 366:1640–9.
and economic consequences of treatment for obesity andimplications for health improvement. Health Technol 163. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up 177. Sharma AM. The obese patient with diabetes mellitus: from of participants in the population study of women in research targets to treatment options. Am J Med 2006; Gothenburg Sweden. Br Med J 1984; 289:1257–61.
164. Kragelund C, Hassager C, Hildebrandt P, Torp-Pedersen C, 178. Lavie CJ, Milani RV. Effects of cardiac rehabilitation, Kober L. TRACE study group. Impact of obesity on long- exercise training, and weight reduction on exercise term prognosis following acute myocardial infarction.
capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol1997; 165. Folsom AR, Kushi LH, Anderson KE, Mink PJ, Olson JE, Hong CP, et al. Associations of general and abdominal 179. Alpert MA. Management of obesity cardiomyopathy. Am J obesity with multiple health outcomes in older women: the Iowa Women’s Health Study. Arch Intern Med 2000; 180. Messier SP, Loeser RF, Miller GD, Morgan TM, Rejeski WJ, Sevick MA, et al. Exercise and dietary weight loss in 166. Lebovitz HE, Banerji MA. Point: Visceral adiposity is overweight and obese older adults with knee osteoarthritis; causally related to insulin resistance. Diabetes Care 2005; the Arthritis, Diet, and Activity Promotion Trial. Arthritis 167. Thorne A, Lonnqvist F, Apelman J, Hellers G, Arner P.
181. Christensen R, Astrup A, Bliddal H. Weight loss: the A pilot study of long-term effects of a novel obesity treatment of choice for knee osteoarthritis? A randomized treatment: omentectomy in connection with adjustable trial. Osteoarthritis Cartilage 2005; 13:20–7.

Source: http://www.h-gastro.info/wp-content/uploads/2012/05/stuven3-%D7%9E%D7%90%D7%9E%D7%A8.pdf

isz.co.tz

GEOGRAPHY Breadth of Study Key Stage 1 • During the key stage, pupils should be taught the Knowledge, skills and understanding through the study of two localities: a) The locality of the school. b) A locality either in the United Kingdom or overseas that has physical and/or human features that contrast with those in the locality of the school. • In their study of localities, pupi

Clinical features, pathophysiology, and treatment of medication-overuse headache

Clinical features, pathophysiology, and treatment of medication-overuse headache Medication-overuse headache (MOH) is a chronic headache disorder defi ned by the International Headache Society Lancet Neurol 2010; 9: 391–401 as a headache induced by the overuse of analgesics, triptans, or other acute headache compounds. The population- See In Context page 349 based prevalence of MOH

Copyright © 2010-2014 Pdf Pills Composition